A Patients Perspective on MDS and AML: Updates from EHA ASCO | Aplastic Anemia & MDS International Foundation

A Patients Perspective on MDS and AML: Updates from EHA ASCO

Presenter(s): 
Topic(s): 
Myelodysplastic Syndromes (MDS)
Acute Myeloid Leukemia (AML)
Presentation Date: 
Friday, November 6, 2020

Dr. Guillermo Garcia-Manero is with the University of Texas MD Anderson Cancer Center where he serves as Chief, Section of Myelodysplastic Syndromes, Deputy Chief, Translational Research and heads up the MDS/AML MoonShot program. Dr. Garcia-Manero also serves on the AAMDSIF Medical Advisory Board. In this webinar, he reviews the most promising research presented at the 2020 European Hematology Association and American Society of Clinical Oncology meetings.